SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kakulavarapu V. Rama Rao, A.S. Verkman, Kevin M. Curtis, Michael D. Norenberg, Aquaporin-4 deletion in mice reduces encephalopathy and brain edema in experimental acute liver failure, Neurobiology of Disease, 2014, 63, 222

    CrossRef

  2. You have free access to this content2
    Javier Fernández-Ruiz, Onintza Sagredo, M. Ruth Pazos, Concepción García, Roger Pertwee, Raphael Mechoulam, José Martínez-Orgado, Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?, British Journal of Clinical Pharmacology, 2013, 75, 2
  3. 3
    L. Brunet, E. E. M. Moodie, K. Rollet, C. Cooper, S. Walmsley, M. Potter, M. B. Klein, Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis, Clinical Infectious Diseases, 2013, 57, 5, 663

    CrossRef

  4. 4
    Amr A. Fouad, Abdulruhman S. Al-Mulhim, Wafaey Gomaa, Protective effect of cannabidiol against cadmium hepatotoxicity in rats, Journal of Trace Elements in Medicine and Biology, 2013, 27, 4, 355

    CrossRef

  5. 5
    Maurizio Baldassarre, Ferdinando A. Giannone, Lucia Napoli, Alessandra Tovoli, Carmen S. Ricci, Manuel Tufoni, Paolo Caraceni, The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives, Liver International, 2013, 33, 9
  6. 6
    Elen V. Fagherazzi, Vanessa A. Garcia, Natasha Maurmann, Thielly Bervanger, Luis H. Halmenschlager, Stefano B. Busato, Jaime E. Hallak, Antônio W. Zuardi, José A. Crippa, Nadja Schröder, Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders, Psychopharmacology, 2012, 219, 4, 1133

    CrossRef

  7. 7
    Paolo Caraceni, Francesca Borrelli, Ferdinando A. Giannone, Angelo A. Izzo, Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology,